MYND Life Sciences Inc. (MYNDF)

0.0227 0.0000 (0.00%) At close: 03:15PM EDT

MYND Life Sciences Inc.

Unit 150
2248 Elgin Avenue
Port Coquitlam, BC V3C 2B2
Canada

https://www.myndsciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Lyle Oberg M.D.	Co-Founder & Executive Chairman of the Board	N/A	N/A	1960
Mr. John Campbell	President,CEO & Director	N/A	N/A	1972
Dr. Wilfred A. Jefferies	Co-Founder & Chief Science Officer	N/A	N/A	1958
Mr. Lih-Ming Tam	CFO & Senior Controller	N/A	N/A	N/A
Dr. Chaahat S.B Singh	Senior Operations & Research Manager	N/A	N/A	N/A
Mr. Luke Warkentin	Vice President of Corporate Development	N/A	N/A	N/A
Dr. Iryna Saranchova Ph.D.	Chief Clinical Officer	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.

Corporate governance

MYND Life Sciences Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.